What's Happening?
New research from Boston Consulting Group (BCG) reveals a significant unmet demand in the longevity market, estimated at $350 billion, specifically from women in perimenopause and menopause. These women are identified as the most engaged and highest-spending
consumers of longevity interventions, adopting them at rates 15 to 22 percentage points higher than other women or men. On average, they have tried 3.3 more interventions than other women and 2.9 more than men. Despite their high engagement and spending—a median of $84 per month compared to $68 for other women and $73 for men—their satisfaction levels remain around 50%, similar to other surveyed groups. The study, titled 'The $350 Billion Longevity Mismatch in Women's Health,' surveyed 10,608 people across 12 countries for the St. Moritz Longevity Forum.
Why It's Important?
This overlooked market segment represents a substantial economic opportunity for businesses in the health and wellness sectors. The current approach by companies, which often begins addressing women's long-term health concerns only at menopause, misses a crucial window. According to Parul Bajaj, a BCG managing director and partner, women's interest in long-term health typically begins a decade earlier, around ages 36 to 38, due to hormonal shifts and fertility challenges. This earlier interest raises their engagement in long-term health by 8 percentage points, nearly double the effect of menopause itself. By failing to cater to these needs earlier and more effectively, the longevity market is not only leaving billions of dollars on the table but also failing to adequately support a demographic actively seeking solutions for their health and well-being.
What's Next?
The findings suggest a need for companies to re-evaluate their strategies for engaging with women regarding longevity and health. There is a clear opportunity to develop and market products and services that address the specific needs of women in their mid-30s and beyond, prior to and during perimenopause and menopause. A third of these women indicated they would spend more (up to $108 a month) for products or services that demonstrate tangible results, indicating a willingness to invest in effective solutions. This could lead to the development of more tailored interventions, research into women-specific longevity solutions, and a shift in marketing approaches to engage women earlier in their health journeys. The focus should move from reactive disease management to proactive optimization and prevention, aligning with the broader trends in longevity medicine.
Beyond the Headlines
The report highlights a deeper issue within the healthcare and wellness industries: a significant blind spot in understanding and addressing women's health needs, particularly as they relate to aging and hormonal changes. This gap is not merely economic but also reflects a systemic oversight in how women's health is perceived and catered to. The emphasis on 'lifespan' versus 'healthspan' is crucial here; women are not just seeking to live longer, but to live well for longer, maintaining strength, mobility, energy, and cognitive function. Addressing this unmet demand could foster a more holistic approach to women's health, encouraging integrated care models that consider nutrition, movement, sleep, stress management, and meaningful relationships as foundational elements for extending healthspan, rather than relying solely on advanced, often unproven, technologies.
